Atopic Dermatitis: When to Refer

Atopic Dermatitis: When to Refer

Enroll

Cost: $FREE
Course Type: Online
Approximate Length: 1 hour

Welcome to training on Pediatric/Adolescent Atopic Dermatitis: When to Refer, provided by the Texas Department of State Health Services (DSHS) and Health and Human Services Commission (HHSC).

Sample Clinical Case

A 6-month-old boy presents with a 2 to 3 month history of rash and pruritus. Multiple food allergies have been documented. The family is not sleeping and the parents are missing work to care for their child. He is irritable, and he has diffuse erythematous scaling and adenopathy.

Diagnosis

Do the baby’s signs and symptoms suggest a diagnosis of atopic dermatitis, as opposed to another inflammatory skin disorder?

Goal

The goal of this module is to educate Texas Health Steps (THSteps) providers and others regarding the recognition and management of pediatric and adolescent patients seen in the primary care setting with atopic dermatitis. Indications for referral to dermatologists will be addressed.

Target Audience

Texas Health Steps providers and other interested health-care providers.

Specific Learning Objectives

After completing the activities of this module, you will be able to:

  1. Indicate the frequency of atopic dermatitis in the pediatric population.
  2. Identify the pathophysiology of atopic dermatitis.
  3. Identify the three primary symptoms of atopic dermatitis.
  4. Select two physical comorbidities of atopic dermatitis.
  5. Select one behavioral comorbidity of atopic dermatitis.
  6. Select two components of making a differential diagnosis of atopic dermatitis.
  7. Indicate three components of information that needs to be communicated to the client and parents/caregivers about the management of atopic dermatitis.
  8. Indicate two topical agents used to treat atopic dermatitis.
  9. Indicate one systemic therapy used to treat severe atopic dermatitis.
  10. Identify one tool for educating parents about the need for compliance with treatment therapies.
  11. Select three situations in which it would be appropriate to refer for management and treatment of atopic dermatitis.

External links in this course are current as of 2/2010. These links may be bookmarked for future reference.

Please note this module expires on 02/05/2011.

Make sure to turn off your browser's popup blocker or allow popups from this site.

Lessons

Enroll in this course to access the lessons below. If you don't have an account, register and then login.

  • Atopic Dermatitis: When to Refer: Pre-Test
  • Section 1: Introduction to Atopic Dermatitis
  • Section 2: Symptoms and Signs
  • Section 3: Comorbidities
  • Section 4: Diagnosis
  • Section 5: Treatment and Management of Atopic Dermatitis
  • Section 6: Patient Education
  • Section 7: Referral
  • Atopic Dermatitis: When to Refer: Course Evaluation
  • Atopic Dermatitis: When to Refer: Post-Test

Certificates

This module includes a pre- and post-test. Both tests need to be completed for you to receive a certificate of completion, and you must score a 75% on the post-test to pass. After you complete the post-test, you will be asked to evaluate your training experience, and you will be provided with information about securing continuing education credit. Click below for your certificate.

Disclosure Statements

One of the requirements of continuing education is disclosure of the following information to the learner:

  1. Notice of requirements for successful completion of continuing education activity. To receive continuing education credit the learner must successfully complete the following activities:
    1. Create a Texas Health Steps account.
    2. Complete on-line registration process.
    3. Thoroughly read the content of the module.
    4. Complete the on-line examination.
    5. Complete the evaluation.
  2. Commercial Support.
    The THSTEPS Web-based Continuing Education Series has received no commercial support.
  3. Disclosure of Conflict of Interest.
    Using a disclosure review process, the THSTEPS Continuing Education Planning Committee has examined documents and has concluded that neither planning committee members nor the authors of these modules have a conflict of interest.
  4. Non-Endorsement Statement.
    Accredited status does not imply endorsement by the Department of State Health Services, Continuing Education Service or the American Nurses Credentialing Center of any commercial products displayed in conjunction with an activity.
  5. Off-Label Use.
    Using a disclosure review process, the THSTEPS Continuing Education Planning Committee has examined documents and has concluded that the authors of these modules have not included content that discusses off-label use (use of products for a purpose other than that for which they were approved by the Food and Drug Administration).

The following are policies and definitions of terms related to continuing education disclosure:

The intent of disclosure is to allow Department of State Health Services (DSHS) Continuing Education Service the opportunity to resolve any potential conflicts of interest to assure balance, independence, objectivity and scientific rigor in all of its Continuing Education activities.

All faculty, planners, speakers and authors of Department of State Health Services (DSHS) Continuing Education Service sponsored activities are expected to disclose to the Department of State Health Services (DSHS) Continuing Education Service any relevant financial, relationships with any commercial or personal interest that produces health care goods or services concerned with the content of an educational presentation. Faculty, planners, speakers and authors must also disclose where there are any other potentially biasing relationships of a professional or personal nature.

↓ Disclosure: Glossary of Terms

Conflict of Interest – Circumstances create a conflict of interest when an individual has an opportunity to affect Continuing Education content about products or services of a commercial interest with which she/he has a financial relationship or where there are any other potentially biasing relationships of a professional or personal nature.

Commercial Interest – Any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients.

Financial Relationships – Those relationships in which the individual benefits by receiving a salary, royalty, intellectual property rights, consulting fee, honoraria, ownership interest (e.g., stocks, stock options or other ownership interest, excluding diversified mutual funds), or other financial benefit. Financial benefits are usually associated with roles such as employment, management position, independent contractor (including contracted research), consulting, teaching, membership on advisory committees or review panels, board membership, and other activities for which remuneration is received or expected. Relevant financial relationships would include those within the past 12 months of the person involved in the activity and a spouse or partner. Relevant financial relationships of your spouse or partner are those of which you are aware at the time of this disclosure.

Off Label – Using products for a purpose other that that for which it was approved by the Food and Drug Administration (FDA).

Execution Time: 0 seconds
Tracking